Frazier Healthcare

Stomach with colon

Biotech

Phathom's erosive esophagitis drug bests Prevacid in phase 3

Phathom Pharmaceuticals' erosive esophagitis drug vonoprazan performed as well as over-the-counter Prevacid in a head-to-head phase 3 clinical trial.

Emmy Lucas Oct 18, 2021 3:10pm

Inipharm raises $35M to combat liver diseases

Nov 11, 2020 8:00am

Nader Naini - Frazier Healthcare Partners

Frazier closes $780M growth buyout fund

Apr 10, 2018 8:50am

Dollars

Biotech vets tap Frazier, Alpine for cash for STING R&D

Nov 29, 2017 8:00am

money

Frazier hits $419M for early-stage biotech investments

Nov 1, 2017 5:00am

Handshake

Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic

May 19, 2017 3:13am